BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15638969)

  • 1. Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux.
    Issing WJ; Karkos PD; Perreas K; Folwaczny C; Reichel O
    J Laryngol Otol; 2004 Nov; 118(11):845-8. PubMed ID: 15638969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
    Issing WJ; Tauber S; Folwaczny C; Reichel O
    Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis.
    Noordzij JP; Khidr A; Desper E; Meek RB; Reibel JF; Levine PA
    Laryngoscope; 2002 Dec; 112(12):2192-5. PubMed ID: 12461340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of laryngopharyngeal reflux].
    Reichel O; Hagedorn H; Berghaus A
    Laryngorhinootologie; 2006 Dec; 85(12):919-24; quiz 925-6. PubMed ID: 17171585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric esomeprazole in the treatment of laryngopharyngeal reflux.
    DelGaudio JM; Waring JP
    Laryngoscope; 2003 Apr; 113(4):598-601. PubMed ID: 12671413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid reflux management: ENT perspective.
    Ahmad I; Batch AJ
    J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
    Issing WJ; Gross M; Tauber S
    Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
    Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is ambulatory 24-h dual-probe pH monitoring useful in suspected ENT manifestations of GERD?
    Sermon F; Vanden Brande S; Roosens B; Mana F; Deron P; Urbain D
    Dig Liver Dis; 2004 Feb; 36(2):105-10. PubMed ID: 15002816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
    Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
    Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngopharyngeal reflux: a modern day "great masquerader".
    Hawkins BL
    J Ky Med Assoc; 1997 Sep; 95(9):379-85. PubMed ID: 9322411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraesophageal manifestations of gastroesophageal reflux disease.
    Al-Sabbagh G; Wo JM
    Semin Gastrointest Dis; 1999 Jul; 10(3):113-9. PubMed ID: 10435698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
    Monini S; Di Stadio A; Vestri A; Barbara M
    Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
    Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
    J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics of gastroesophageal reflux disease in patients with laryngeal symptoms who are referred to gastroenterology.
    Oh JH; Choi MG; Park JM; Lim CH; Cho YK; Lee IS; Kim SW; Chung IS
    Dis Esophagus; 2013 Jul; 26(5):465-9. PubMed ID: 22816650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Typical and atypical symptoms of laryngopharyngeal reflux disease].
    Pribuisiene R; Uloza V; Jonaitis L
    Medicina (Kaunas); 2002; 38(7):699-705. PubMed ID: 12474654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.
    Koufman JA
    Laryngoscope; 1991 Apr; 101(4 Pt 2 Suppl 53):1-78. PubMed ID: 1895864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.